Federal Register Notice: FDA is making available the final decision setting forth the findings of fact and conclusions of law on the issues addressed in a formal evidentiary public hearing to determine whether FDA should withdraw approval of the new animal drug application (NADA) for using enrofloxacin in poultry. Once this final decision becomes effective on 9/12, this drug may no longer be distributed or administered for this use in the U.S., nor may it be exported except as allowed by law. To view this notice, click here.